Differential Remodeling of Actin Cytoskeleton Architecture by Profilin Isoforms Leads to Distinct Effects on Cell Migration and Invasion

Cancer Cell

Volumn 22, Issue 5, 2012, Pages 615-630

  Mouneimne, Ghassan ^a   Hansen, Scott D ^b   Selfors, Laura M ^a   Petrak, Lara ^a   Hickey, Michele M ^a   Gallegos, Lisa L ^a   Simpson, Kaylene J ^c,d   Lim, James ^a   Gertler, Frank B ^e   Hartwig, John H ^a   Mullins, R Dyche ^b   Brugge, Joan S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CARRIER PROTEINS AND BINDING PROTEINS; ENA PROTEIN; EVL PROTEIN; MEMBRANE PROTEIN; MYOSIN ADENOSINE TRIPHOSPHATASE; PROFILIN; PROFILIN I; PROFILIN II; UNCLASSIFIED DRUG; VASODILATOR STIMULATED PHOSPHOPROTEIN;

ACTIN FILAMENT; ACTIN POLYMERIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL; CANCER PATIENT; CELL DIFFERENTIATION; CELL INVASION; CELL MEMBRANE; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MEDIATOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION; TUMOR XENOGRAFT;

EID: 84869045388     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccr.2012.09.027     Document Type: Article

References (47)

1. Bae Y.H., Ding Z., Zou L., Wells A., Gertler F., Roy P. Loss of profilin-1 expression enhances breast cancer cell motility by Ena/VASP proteins. J. Cell. Physiol. 2009, 219:354-364.
2. Bear J.E., Gertler F.B. Ena/VASP: towards resolving a pointed controversy at the barbed end. J. Cell Sci. 2009, 122:1947-1953.
3. Bieling P., Telley I.A., Hentrich J., Piehler J., Surrey T. Fluorescence microscopy assays on chemically functionalized surfaces for quantitative imaging of microtubules, motors, and + TIP dynamics. Methods Cell Biol. 2010, 95:549-574.
4. Breitsprecher D., Kiesewetter A.K., Linkner J., Vinzenz M., Stradal T.E., Small J.V., Curth U., Dickinson R.B., Faix J. Molecular mechanism of Ena/VASP-mediated actin-filament elongation. EMBO J. 2011, 30:456-467.
5. Debnath J., Brugge J.S. Modelling glandular epithelial cancers in three-dimensional cultures. Nat. Rev. Cancer 2005, 5:675-688.
6. DesMarais V., Ghosh M., Eddy R., Condeelis J. Cofilin takes the lead. J. Cell Sci. 2005, 118:19-26.
7. Desmedt C., Piette F., Loi S., Wang Y., Lallemand F., Haibe-Kains B., Viale G., Delorenzi M., Zhang Y., d'Assignies M.S., et al. Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series. Clin. Cancer Res. 2007, 13:3207-3214. TRANSBIG Consortium.
8. Di Nardo A., Gareus R., Kwiatkowski D., Witke W. Alternative splicing of the mouse profilin II gene generates functionally different profilin isoforms. J. Cell Sci. 2000, 113:3795-3803.
9. Ferron F., Rebowski G., Lee S.H., Dominguez R. Structural basis for the recruitment of profilin-actin complexes during filament elongation by Ena/VASP. EMBO J. 2007, 26:4597-4606.
10. Fischer R.S., Gardel M., Ma X., Adelstein R.S., Waterman C.M. Local cortical tension by myosin II guides 3D endothelial cell branching. Curr. Biol. 2009, 19:260-265.
11. Friedl P., Wolf K. Plasticity of cell migration: a multiscale tuning model. J. Cell Biol. 2010, 188:11-19.
12. Gertler F.B., Niebuhr K., Reinhard M., Wehland J., Soriano P. Mena, a relative of VASP and Drosophila Enabled, is implicated in the control of microfilament dynamics. Cell 1996, 87:227-239.
13. Grady W.M., Parkin R.K., Mitchell P.S., Lee J.H., Kim Y.H., Tsuchiya K.D., Washington M.K., Paraskeva C., Willson J.K., Kaz A.M., et al. Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer. Oncogene 2008, 27:3880-3888.
14. Hansen S.D., Mullins R.D. VASP is a processive actin polymerase that requires monomeric actin for barbed end association. J. Cell Biol. 2010, 191:571-584.
15. Honoré B., Madsen P., Andersen A.H., Leffers H. Cloning and expression of a novel human profilin variant, profilin II. FEBS Lett. 1993, 330:151-155.
16. Hu L.D., Zou H.F., Zhan S.X., Cao K.M. EVL (Ena/VASP-like) expression is up-regulated in human breast cancer and its relative expression level is correlated with clinical stages. Oncol. Rep. 2008, 19:1015-1020.
17. Insall R.H., Machesky L.M. Actin dynamics at the leading edge: from simple machinery to complex networks. Dev. Cell 2009, 17:310-322.
18. Ivshina A.V., George J., Senko O., Mow B., Putti T.C., Smeds J., Lindahl T., Pawitan Y., Hall P., Nordgren H., et al. Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. Cancer Res. 2006, 66:10292-10301.
19. Jockusch B.M., Murk K., Rothkegel M. The profile of profilins. Rev. Physiol. Biochem. Pharmacol. 2007, 159:131-149.
20. Kursula P., Kursula I., Massimi M., Song Y.H., Downer J., Stanley W.A., Witke W., Wilmanns M. High-resolution structural analysis of mammalian profilin 2a complex formation with two physiological ligands: the formin homology 1 domain of mDia1 and the proline-rich domain of VASP. J. Mol. Biol. 2008, 375:270-290.
21. Lambrechts A., Verschelde J.L., Jonckheere V., Goethals M., Vandekerckhove J., Ampe C. The mammalian profilin isoforms display complementary affinities for PIP2 and proline-rich sequences. EMBO J. 1997, 16:484-494.
22. Lambrechts A., Kwiatkowski A.V., Lanier L.M., Bear J.E., Vandekerckhove J., Ampe C., Gertler F.B. cAMP-dependent protein kinase phosphorylation of EVL, a Mena/VASP relative, regulates its interaction with actin and SH3 domains. J. Biol. Chem. 2000, 275:36143-36151.
23. Loi S., Haibe-Kains B., Desmedt C., Lallemand F., Tutt A.M., Gillet C., Ellis P., Harris A., Bergh J., Foekens J.A., et al. Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade. J. Clin. Oncol. 2007, 25:1239-1246.
24. Lu X., Lu X., Wang Z.C., Iglehart J.D., Zhang X., Richardson A.L. Predicting features of breast cancer with gene expression patterns. Breast Cancer Res. Treat. 2008, 108:191-201.
25. Ma C.Y., Zhang C.P., Zhong L.P., Pan H.Y., Chen W.T., Wang L.Z., Andrew O.W., Ji T., Han W. Decreased expression of profilin-2 in oral squamous cell carcinoma and its clinicopathological implications. Oncol. Rep. 2011, 26:813-823.
26. Mahoney N.M., Janmey P.A., Almo S.C. Structure of the profilin-poly-L-proline complex involved in morphogenesis and cytoskeletal regulation. Nat. Struct. Biol. 1997, 4:953-960.
27. Miki H., Suetsugu S., Takenawa T. WAVE, a novel WASP-family protein involved in actin reorganization induced by Rac. EMBO J. 1998, 17:6932-6941.
28. Minn A.J., Gupta G.P., Siegel P.M., Bos P.D., Shu W., Giri D.D., Viale A., Olshen A.B., Gerald W.L., Massagué J. Genes that mediate breast cancer metastasis to lung. Nature 2005, 436:518-524.
29. Muthuswamy S.K., Li D., Lelievre S., Bissell M.J., Brugge J.S. ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini. Nat. Cell Biol. 2001, 3:785-792.
30. Nakamura F., Stossel T.P., Hartwig J.H. The filamins: organizers of cell structure and function. Cell Adhes. Migr. 2011, 5:160-169.
31. Neve R.M., Chin K., Fridlyand J., Yeh J., Baehner F.L., Fevr T., Clark L., Bayani N., Coppe J.P., Tong F., et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 2006, 10:515-527.
32. Nodelman I.M., Bowman G.D., Lindberg U., Schutt C.E. X-ray structure determination of human profilin II: A comparative structural analysis of human profilins. J. Mol. Biol. 1999, 294:1271-1285.
33. Petersen O.W., Rønnov-Jessen L., Howlett A.R., Bissell M.J. Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc. Natl. Acad. Sci. USA 1992, 89:9064-9068.
34. Pollard T.D., Borisy G.G. Cellular motility driven by assembly and disassembly of actin filaments. Cell 2003, 112:453-465.
35. Reinhard M., Giehl K., Abel K., Haffner C., Jarchau T., Hoppe V., Jockusch B.M., Walter U. The proline-rich focal adhesion and microfilament protein VASP is a ligand for profilins. EMBO J. 1995, 14:1583-1589.
36. Schmidt M., Böhm D., von Törne C., Steiner E., Puhl A., Pilch H., Lehr H.A., Hengstler J.G., Kölbl H., Gehrmann M. The humoral immune system has a key prognostic impact in node-negative breast cancer. Cancer Res. 2008, 68:5405-5413.
37. Sanz-Moreno V., Gadea G., Ahn J., Paterson H., Marra P., Pinner S., Sahai E., Marshall C.J. Rac activation and inactivation control plasticity of tumor cell movement. Cell 2008, 135:510-523.
38. Sanz-Moreno V., Gaggioli C., Yeo M., Albrengues J., Wallberg F., Viros A., Hooper S., Mitter R., Féral C.C., Cook M., et al. ROCK and JAK1 signaling cooperate to control actomyosin contractility in tumor cells and stroma. Cancer Cell 2011, 20:229-245.
39. Sheetz M.P., Sable J.E., Döbereiner H.G. Continuous membrane-cytoskeleton adhesion requires continuous accommodation to lipid and cytoskeleton dynamics. Annu. Rev. Biophys. Biomol. Struct. 2006, 35:417-434.
40. Simpson K.J., Selfors L.M., Bui J., Reynolds A., Leake D., Khvorova A., Brugge J.S. Identification of genes that regulate epithelial cell migration using an siRNA screening approach. Nat. Cell Biol. 2008, 10:1027-1038.
41. van de Vijver M.J., He Y.D., van't Veer L.J., Dai H., Hart A.A., Voskuil D.W., Schreiber G.J., Peterse J.L., Roberts C., Marton M.J., et al. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 2002, 347:1999-2009.
42. Veniere S., Ampe C., Vandekerckhove J., Lambrechts A. The interaction of proline-rich ligands with profilin probed with an enzyme-linked immunosorbent assay. J. Biomol. Screen. 2009, 14:350-359.
43. Witke W. The role of profilin complexes in cell motility and other cellular processes. Trends Cell Biol. 2004, 14:461-469.
44. Witke W., Podtelejnikov A.V., Di Nardo A., Sutherland J.D., Gurniak C.B., Dotti C., Mann M. In mouse brain profilin I and profilin II associate with regulators of the endocytic pathway and actin assembly. EMBO J. 1998, 17:967-976.
45. Witt A.E., Hines L.M., Collins N.L., Hu Y., Gunawardane R.N., Moreira D., Raphael J., Jepson D., Koundinya M., Rolfs A., et al. Functional proteomics approach to investigate the biological activities of cDNAs implicated in breast cancer. J. Proteome Res. 2006, 5:599-610.
46. Yi J.M., Dhir M., Van Neste L., Downing S.R., Jeschke J., Glöckner S.C., de Freitas Calmon M., Hooker C.M., Funes J.M., Boshoff C., et al. Genomic and epigenomic integration identifies a prognostic signature in colon cancer. Clin. Cancer Res. 2011, 17:1535-1545.
47. Zou L., Jaramillo M., Whaley D., Wells A., Panchapakesa V., Das T., Roy P. Profilin-1 is a negative regulator of mammary carcinoma aggressiveness. Br. J. Cancer 2007, 97:1361-1371.